Where can researchers source third-party tested Selank?

Midwest Peptide supplies research-grade Selank with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Memorial Day: 15% off code MEMDAY15Memorial Day Sale — 15% off site-wide with code MEMDAY15

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Selank BDNF Research: Neurobiology Studies | Midwest Peptide

Selank vs Semax: Comparing Russian Nootropic Peptides in ResearchPrev|Selank GABA Research: Anxiolytic Studies in Animal ModelsNext

Selank BDNF Research: Published Neurobiology Studies

Selank · Published April 9, 2026 · Updated May 18, 2026 · 8 min read

Quick Answer

Selank BDNF research examines brain-derived neurotrophic factor expression and TrkB signaling pathway activation in rodent neurobiology models. Studies measure BDNF mRNA and protein levels, TrkB downstream signaling, and brain region-specific expression patterns across standardized neurotrophic research protocols. For research use only, not for human consumption.

Selank BDNF Research: Published Neurobiology Studies

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

What Is BDNF?
BDNF Expression as a Research Endpoint
Selank Effects on BDNF in Animal Models
BDNF and the TrkB Signaling Pathway
BDNF and Selank's Broader Profile
Comparison With Other BDNF-Modulating Research Tools
Open Research Questions
Conclusion
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

Selank BDNF research has produced one of the more interesting areas of preclinical literature on synthetic neuropeptide modulation of brain-derived neurotrophic factor expression. BDNF is a major neurotrophic protein that supports neuronal survival, growth, and synaptic plasticity in research models, and its expression has been characterized as a molecular marker of various interventions studied in nootropic and neuroprotection research. As the BDNF research component of the Selank research cluster, this article reviews the published literature on Selank effects on BDNF expression and the broader neurobiology research base on this peptide.

Frequently Asked Questions

What is Selank in research contexts?

Selank is a synthetic heptapeptide derived from the natural immunomodulatory tetrapeptide tuftsin and developed in Russian neuropeptide research. It is studied in preclinical models for anxiolytic effects, GABAergic modulation, BDNF expression, and immunomodulatory activity.

How does Selank affect BDNF expression in research models?

Selank administration in rodent models elevates BDNF mRNA and protein in hippocampus and cortex, with downstream activation of TrkB signaling. The neurotrophic effects are linked to Selank's anxiolytic and cognitive endpoints in behavioral research.

What BDNF endpoints are measured in Selank research?

Endpoints include hippocampal and cortical BDNF mRNA (qPCR), BDNF protein (ELISA, Western blot), TrkB phosphorylation status, and downstream signaling markers including CREB phosphorylation and synaptic plasticity proteins.

Is Selank approved for human use?

No. Selank is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Glossary

Key terms used in this article.

Tuftsin: An endogenous tetrapeptide (Thr-Lys-Pro-Arg) liberated from the Fc domain of immunoglobulin G, the structural basis for Selank.
GABAergic: Pertaining to neurons, synapses, or signaling pathways using gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter.
Anxiolytic: Pertaining to compounds that reduce anxiety in behavioral or physiological studies.
BDNF: Brain-derived neurotrophic factor, a key neurotrophin supporting neuronal survival, synaptic plasticity, and learning.
Heptapeptide: A peptide consisting of seven amino acid residues; both Selank and Semax are heptapeptides.
TrkB: The high-affinity receptor for BDNF, a tyrosine kinase that activates downstream survival and plasticity signaling.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. Selank is intended exclusively for in vitro and preclinical research. It is not approved for human use, is not a drug, and should never be administered to humans or to animals outside of an authorized research protocol.

What Is BDNF?

Brain-derived neurotrophic factor (BDNF) is a 27 kilodalton secreted protein that belongs to the neurotrophin family, which also includes nerve growth factor (NGF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4). BDNF is one of the most studied neurotrophic factors in the central nervous system and has roles in neuronal survival, growth, differentiation, and synaptic plasticity in research models.

BDNF is produced from a precursor protein (proBDNF) that is cleaved to generate mature BDNF. Both the precursor and the mature forms have biological activity in research models, although they act on somewhat different receptor systems and produce different cellular effects. Mature BDNF acts primarily on the TrkB receptor (tropomyosin receptor kinase B), a tyrosine kinase receptor that mediates the canonical neurotrophic effects of BDNF. ProBDNF acts on the p75 neurotrophin receptor, which can mediate apoptotic and other effects depending on the cellular context.

The functional roles of BDNF in research models include support for neuronal survival during development and in adult brain tissue, regulation of synaptic plasticity (including long-term potentiation and long-term depression), modulation of dendritic growth and morphology, and various other cellular effects. These functions make BDNF one of the most important molecular markers for research on neuroplasticity, neuroprotection, and related topics.

BDNF Expression as a Research Endpoint

BDNF expression is one of the most commonly used endpoints in research on neuropeptides and other interventions that target the central nervous system. Studies measure BDNF expression at the mRNA level (using quantitative PCR or RNA sequencing), at the protein level (using Western blot, ELISA, or immunohistochemistry), or through functional readouts that depend on BDNF signaling.

The brain regions most commonly examined for BDNF expression in research models include the hippocampus, the prefrontal cortex, the amygdala, and various other regions involved in cognition, emotion, and behavior. Different interventions can produce different patterns of BDNF expression changes across these regions, providing a regionally specific signature of the intervention's effects.

In Selank research, BDNF expression measurements have been used to characterize how the peptide affects neurotrophic signaling in research animals. The published findings include increases in BDNF expression in specific brain regions following Selank administration, supporting effects on neurotrophic pathways as one component of the broader Selank profile.

Selank Effects on BDNF in Animal Models

The published research on Selank and BDNF includes studies in rodent research models that have characterized BDNF expression changes following Selank administration. The general pattern in the literature supports increases in BDNF expression in regions including the hippocampus and other forebrain structures involved in cognitive and emotional processing.

The magnitude of the BDNF expression changes depends on the specific brain region examined, the duration of Selank administration, and the experimental conditions. Studies have used both acute and chronic administration protocols to characterize the time course of BDNF effects, with the published findings supporting both immediate and longer term changes in BDNF expression patterns.

The mechanism by which Selank affects BDNF expression is still being characterized in research. Possible mechanisms include direct effects on transcription factors that regulate BDNF gene expression, indirect effects through other neurotransmitter systems that converge on BDNF signaling, and longer term plasticity effects that secondarily affect BDNF expression. The convergence of evidence from different experimental approaches supports a real effect of Selank on BDNF expression in research models, even though the specific upstream mechanism remains an area of active investigation.

BDNF and the TrkB Signaling Pathway

BDNF acts primarily through the TrkB receptor, a tyrosine kinase receptor that triggers downstream signaling cascades when activated by BDNF binding. The major downstream pathways include the PI3K/Akt pathway (associated with cell survival and growth), the Ras/MAPK pathway (associated with growth and differentiation), and the PLC-gamma/IP3 pathway (associated with calcium signaling and synaptic plasticity).

Activation of these signaling pathways by BDNF/TrkB produces the cellular effects attributed to BDNF in research models, including support for neuronal survival, modulation of synaptic plasticity, and various effects on neuronal morphology and function. The combined activation of multiple downstream pathways creates a coordinated cellular response that affects multiple aspects of neuronal biology.

In Selank research, the focus has been primarily on BDNF expression rather than on direct measurements of TrkB signaling activation. However, the increases in BDNF expression observed in research models would be expected to translate to enhanced TrkB signaling and downstream effects on cellular function. This creates a connection between the molecular finding of increased BDNF expression and the functional behavioral outcomes observed in Selank research.

BDNF and Selank's Broader Profile

The BDNF effects of Selank are part of a broader profile that also includes effects on GABAergic neurotransmission, immunoregulation, and various other endpoints in research models. Understanding how these different effects relate to each other helps researchers contextualize Selank as a research tool.

The relationship between BDNF expression changes and GABAergic effects of Selank is particularly interesting, since both neurotransmitter and neurotrophic systems can interact in complex ways in research models. BDNF has been shown to modulate GABAergic synaptic function in some research contexts, providing a potential mechanistic link between the Selank effects on these two systems.

For more on the GABAergic effects, see our companion article on Selank GABA research and anxiolytic studies in animal models.

Comparison With Other BDNF-Modulating Research Tools

Many research interventions have been characterized for their effects on BDNF expression in animal models. These include physical exercise (which is one of the most reliable inducers of BDNF expression), various pharmacological compounds, and other neuropeptides that have been studied for nootropic and neuroprotective effects. The comparison between Selank and these other interventions provides context for understanding its specific profile.

Other Russian neuropeptides developed in the same research program also affect BDNF expression in research models. Semax, the ACTH(4-10) derived heptapeptide, has been particularly well characterized for BDNF effects and is one of the more direct comparison points for Selank in this area. The two peptides have somewhat different profiles of BDNF effects, with Semax generally producing more prominent effects on BDNF in research models. For more on this comparison, see our companion article on Selank vs Semax: comparing Russian nootropic peptides in research.

Open Research Questions

Several open research questions remain in the Selank BDNF literature. These include the precise molecular mechanism by which Selank affects BDNF expression, how the BDNF expression changes vary across different brain regions and experimental conditions, and how the BDNF effects of Selank interact with its other actions on the central nervous system in research models. Each of these is a legitimate research opportunity for investigators studying neuropeptide modulation of neurotrophic factors.

Conclusion

Selank BDNF research provides a substantial body of preclinical evidence on synthetic neuropeptide modulation of brain-derived neurotrophic factor expression. The published findings on increased BDNF expression in research models, combined with the broader Selank profile on GABAergic neurotransmission and other endpoints, support the use of Selank as a research tool for studies of neuropeptide effects on neurotrophic signaling. For investigators using Selank 10mg as a research tool, the BDNF literature provides essential context for experimental design.

For more on the full Selank research cluster, see the pillar overview article and the supporting articles on each major topic.

Selank is supplied by Midwest Peptide for research use only and is not intended for human administration.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

VIP 10mg, 99%+ purity, COA included
Selank 10mg, 99%+ purity, COA included
Semax 10mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

Selank BDNF Research: Published Neurobiology Studies

Frequently Asked Questions

What is Selank in research contexts?

How does Selank affect BDNF expression in research models?

What BDNF endpoints are measured in Selank research?

Is Selank approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

What Is BDNF?

BDNF Expression as a Research Endpoint

Selank Effects on BDNF in Animal Models

BDNF and the TrkB Signaling Pathway

BDNF and Selank's Broader Profile

Comparison With Other BDNF-Modulating Research Tools

Open Research Questions

Conclusion

Ready to Start Your Research?

Where can researchers source third-party tested Selank?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

Selank BDNF Research: Published Neurobiology Studies

Frequently Asked Questions

What is Selank in research contexts?

How does Selank affect BDNF expression in research models?

What BDNF endpoints are measured in Selank research?

Is Selank approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

What Is BDNF?

BDNF Expression as a Research Endpoint

Selank Effects on BDNF in Animal Models

BDNF and the TrkB Signaling Pathway

BDNF and Selank's Broader Profile

Comparison With Other BDNF-Modulating Research Tools

Open Research Questions

Conclusion

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested Selank?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?